Skip to main content

Animations

MJFF Publications

5451 - 5460 of 8587 Results
Title
Year
  • Year
  • 2015
  • 2021
  • 2025
  • 2018
  • 2021
  • 2010
  • 2018
  • 2017
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients
    Journal Name: Gene
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gene.2015.04.035
    Citation Count: 73
  • Summary Details
    RESTRICTED
    Title: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6
    Best OA location URL:
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Splicing accuracy varies across human introns, tissues, age and disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-55607-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0235-y
    Citation Count: 106
  • Summary Details
    OPEN
    Title: miRMaster 2.0: multi-species non-coding RNA sequencing analyses at scale
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkab268
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27361
    Citation Count: 180
  • Summary Details
    RESTRICTED
    Title: Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27035
    Best OA location URL:
    Citation Count: 85
  • Summary Details
    RESTRICTED
    Title: Machine learning methods for optimal prediction of motor outcome in Parkinson’s disease
    Journal Name: Physica Medica
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmp.2019.12.022
    Best OA location URL:
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum
    Journal Name: ACS Central Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1021/acscentsci.8b00879
    Citation Count: 145
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.